;)
Issue Lab
Every day, more than 1,000,000 biopharmaceutical industry employees across the United States work to research, develop and manufacture lifesaving medicines and treatments. It is important to have public policies that encourage and support continued medical innovation, while also improving patient access to affordable medicines.
We aim to protect access, innovation and jobs.
Unfortunately, some policymakers have proposed policies that would chill investment in science, threaten access to medicines and put jobs at risk.
Employee Champions
Meet the recipients of the 2024 Employee Champions Awards. This award recognizes individuals who strive to advance science and support innovation so that patients around the world can get the medicines and treatments they need.
Mike Edmondson
Vice President
Amgen
Liv Gagne
Lead, Patient Partnerships
Astellas
Shaun Venable
Head of Corporate Communications at Biogen’s Research Triangle Park (RTP) Campus
Biogen
Neil Bence
Vice President of Cancer Biology
Bristol Myers Squibb
Ram Gupta
Director, National Accounts
Genmab
Dr. Jim Hartke
Vice President, Nonclinical Safety and Pathobiology
Gilead Sciences
John Capriotti
Sr. Director, Market Access, Contract Operations
GSK
Pearl Pugh
President of Neuroscience
Johnson & Johnson
Petr Vachal, Ph.D.
Associate Vice President, Discovery Chemistry
Merck
Ian Hunt
Global Head of Scientific Engagement
Novartis
Dr. Megan O’Meara
Head of Oncology Early-Stage Development
Pfizer
Dr. Jeffrey Stark
Vice President and Head, U.S. Medical Immunology
UCB